Page last updated: 2024-10-31

moclobemide and Hypochondriacal Neuroses

moclobemide has been researched along with Hypochondriacal Neuroses in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
" neuroticism and hypochondriasis) in the reporting of somatic symptoms-both in clinical and in nonclinical research-the recognition of the moderating role of individual differences in the frequency and intensity of side effect reporting is virtually absent from drug trial research."2.68The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. ( Davis, C; Kennedy, SH; Neitzert, C; Ralevski, E, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, C1
Ralevski, E1
Kennedy, SH1
Neitzert, C1

Trials

1 trial available for moclobemide and Hypochondriacal Neuroses

ArticleYear
The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Antidepressive Agents; Benzamides; Bias; Double-Blind Method; Female; Humans; Hyp

1995